Australia markets closed

YS Biopharma Co., Ltd. (YS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.9501-0.0149 (-1.54%)
At close: 04:00PM EDT
0.9401 -0.01 (-1.05%)
After hours: 07:18PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
560,759
687,201
502,950
257,016
Cost of revenue
111,847
153,360
117,066
59,657
Gross profit
448,912
533,841
385,884
197,359
Operating expenses
Research development
373,693
318,701
211,222
94,387
Selling general and administrative
358,817
333,321
272,766
208,327
Total operating expenses
735,468
647,151
481,822
319,676
Operating income or loss
-286,555
-113,310
-95,938
-122,317
Interest expense
30,568
30,858
2,717
29,690
Total other income/expenses net
6,303
-178.094
-2,412
-22,365
Income before tax
-309,129
-144,346
-101,067
-174,372
Income tax expense
-252.474
1,134
4,937
17,454
Income from continuing operations
-308,877
-145,479
-106,004
-191,826
Net income
-308,877
-145,479
-106,004
-191,826
Net income available to common shareholders
-374,785
-283,471
-236,667
-208,437
Basic EPS
-3.21
-3.05
-2.57
-2.26
Diluted EPS
-3.21
-3.05
-2.57
-2.26
Basic average shares
93,058
93,058
92,175
92,175
Diluted average shares
93,058
93,058
92,175
92,175